CLEC2B and cancer: Our findings revealed that CLEC2B was correlated with most immunoinhibitors and immunostimulators in multiple cancer types (Fig. 10B), suggesting that CLEC2B could collectively influence the prognosis of multiple cancers through immunosurveillance.